Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Diabetes | Research

High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study

Authors: Jining He, Sheng Yuan, Chenxi Song, Yanjun Song, Xiaohui Bian, Guofeng Gao, Kefei Dou

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

Coronary bifurcation lesion, as a complex coronary lesion, is associated with higher risk of long-term poor prognosis than non-bifurcation lesions. The triglyceride-glucose (TyG) index has been shown to predict cardiovascular (CV) events in patients with coronary artery disease (CAD). However, the prognostic value of the TyG index in patients with bifurcation lesions who are at high risk of CV events remains undetermined. Therefore, this study aimed to investigate the association between the TyG index and CV events in patients with bifurcation lesions.

Methods

A total of 4530 consecutive patients with angiography-proven CAD and bifurcation lesions were included in this study from January 2017 to December 2018. The TyG index was calculated as Ln [fasting triglyceride (mg/dL) × fasting plasma glucose (mg/dL)/2]. Patients were assigned into 3 groups according to TyG tertiles (T) (T1: <8.633; T2: 8.633–9.096 and T3: ≥9.096). The primary endpoint was CV events, including CV death, nonfatal myocardial infarction and nonfatal stroke at 3-year follow-up. Restricted cubic spline (RCS) analysis, Kaplan-Meier curves and Cox proportional hazard models were used to investigate the associations between the TyG index and study endpoints.

Results

During a median follow-up of 3.1 years, 141 (3.1%) CV events occurred. RCS analysis demonstrated a linear relationship between the TyG index and events after adjusting for age and male sex (non-linear P = 0.262). After multivariable adjustments, elevated TyG index (both T2 and T3) was significantly associated with the risk of CV events (hazard ratio [HR], 1.68; 95% confidence interval [CI],1.06–2.65; HR, 2.10; 95%CI, 1.28–3.47, respectively). When study patients were further stratified according to glycemic status, higher TyG index was associated with significantly higher risk of CV events in diabetic patients after adjusting for confounding factors (T3 vs. T1; HR, 2.68; 95%CI, 1.17–6.11). In addition, subgroup analysis revealed consistent associations of the TyG index with 3-year CV events across various subgroups. Furthermore, adding the TyG index to the original model significantly improved the predictive performance.

Conclusions

High TyG index was associated with CV events in patients with bifurcation lesions, suggesting the TyG index could help in risk stratification and prognosis in this population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dou K, Zhang D, Xu B, et al. An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (risk prEdiction of side branch OccLusion in coronary bifurcation interVEntion). JACC Cardiovasc Interv. 2015;8(1 Pt A):39–46.CrossRefPubMed Dou K, Zhang D, Xu B, et al. An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (risk prEdiction of side branch OccLusion in coronary bifurcation interVEntion). JACC Cardiovasc Interv. 2015;8(1 Pt A):39–46.CrossRefPubMed
2.
go back to reference Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and interventions. Circulation. 2011;124(23):e574–651.PubMed Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and interventions. Circulation. 2011;124(23):e574–651.PubMed
3.
go back to reference Ninomiya K, Serruys PW, Garg S, et al. Predicted and observed mortality at 10 years in patients with bifurcation lesions in the SYNTAX trial. JACC Cardiovasc Interv. 2022;15(12):1231–42.CrossRefPubMed Ninomiya K, Serruys PW, Garg S, et al. Predicted and observed mortality at 10 years in patients with bifurcation lesions in the SYNTAX trial. JACC Cardiovasc Interv. 2022;15(12):1231–42.CrossRefPubMed
4.
go back to reference Pan M, Lassen JF, Burzotta F, et al. The 17th expert consensus document of the European Bifurcation Club - techniques to preserve access to the side branch during stepwise provisional stenting. EuroIntervention. 2023;19(1):26–36.CrossRefPubMed Pan M, Lassen JF, Burzotta F, et al. The 17th expert consensus document of the European Bifurcation Club - techniques to preserve access to the side branch during stepwise provisional stenting. EuroIntervention. 2023;19(1):26–36.CrossRefPubMed
5.
go back to reference Mauri L, Hsieh W-h, Massaro JM, et al. Stent Thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.CrossRefPubMed Mauri L, Hsieh W-h, Massaro JM, et al. Stent Thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.CrossRefPubMed
6.
go back to reference Tao L-C, Xu J-N, Wang T-T, et al. Triglyceride-glucose index as a marker in Cardiovascular Diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral Tao L-C, Xu J-N, Wang T-T, et al. Triglyceride-glucose index as a marker in Cardiovascular Diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral
7.
go back to reference Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with Hypertension. J Clin Hypertens (Greenwich). 2021;23(3):529–37.CrossRefPubMed Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with Hypertension. J Clin Hypertens (Greenwich). 2021;23(3):529–37.CrossRefPubMed
8.
go back to reference Song Y, Cui K, Yang M, et al. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22(1):180.CrossRefPubMedPubMedCentral Song Y, Cui K, Yang M, et al. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22(1):180.CrossRefPubMedPubMedCentral
9.
go back to reference Su J, Li Z, Huang M, et al. Triglyceride glucose index for the detection of the severity of coronary artery Disease in different glucose metabolic states in patients with coronary Heart Disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):96.CrossRefPubMedPubMedCentral Su J, Li Z, Huang M, et al. Triglyceride glucose index for the detection of the severity of coronary artery Disease in different glucose metabolic states in patients with coronary Heart Disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):96.CrossRefPubMedPubMedCentral
10.
go back to reference Ding X, Wang X, Wu J, et al. Triglyceride-glucose index and the incidence of atherosclerotic Cardiovascular Diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.CrossRefPubMedPubMedCentral Ding X, Wang X, Wu J, et al. Triglyceride-glucose index and the incidence of atherosclerotic Cardiovascular Diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.CrossRefPubMedPubMedCentral
11.
go back to reference Lunardi M, Louvard Y, Lefèvre T, et al. Definitions and standardized endpoints for treatment of coronary bifurcations. J Am Coll Cardiol. 2022;80(1):63–88.CrossRefPubMed Lunardi M, Louvard Y, Lefèvre T, et al. Definitions and standardized endpoints for treatment of coronary bifurcations. J Am Coll Cardiol. 2022;80(1):63–88.CrossRefPubMed
12.
go back to reference Chen SL, Sheiban I, Xu B, et al. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts). JACC Cardiovasc Interv. 2014;7(11):1266–76.CrossRefPubMed Chen SL, Sheiban I, Xu B, et al. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts). JACC Cardiovasc Interv. 2014;7(11):1266–76.CrossRefPubMed
13.
go back to reference He J, Song C, Wang H et al. Diabetes Mellitus with mild or moderate kidney dysfunction is Associated with poor prognosis in patients with coronary artery Disease: a large-scale cohort study. Diabetes Res Clin Pract. 2023:110693. He J, Song C, Wang H et al. Diabetes Mellitus with mild or moderate kidney dysfunction is Associated with poor prognosis in patients with coronary artery Disease: a large-scale cohort study. Diabetes Res Clin Pract. 2023:110693.
14.
go back to reference He J, Lin Z, Song C, et al. High absolute neutrophil count with type 2 Diabetes is associated with adverse outcome in patients with coronary artery Disease: a large-scale cohort study. Front Endocrinol (Lausanne). 2023;14:1129633.CrossRefPubMed He J, Lin Z, Song C, et al. High absolute neutrophil count with type 2 Diabetes is associated with adverse outcome in patients with coronary artery Disease: a large-scale cohort study. Front Endocrinol (Lausanne). 2023;14:1129633.CrossRefPubMed
15.
go back to reference Jin J-L, Sun D, Cao Y-X, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in Diabetes patients with new-onset, stable coronary artery Disease: a nested case-control study. Ann Med. 2018;50(7):576–86.CrossRefPubMed Jin J-L, Sun D, Cao Y-X, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in Diabetes patients with new-onset, stable coronary artery Disease: a nested case-control study. Ann Med. 2018;50(7):576–86.CrossRefPubMed
16.
go back to reference Yang J, Tang Y-D, Zheng Y, et al. The impact of the triglyceride-glucose index on poor prognosis in NonDiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol (Lausanne). 2021;12:710240.CrossRefPubMed Yang J, Tang Y-D, Zheng Y, et al. The impact of the triglyceride-glucose index on poor prognosis in NonDiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol (Lausanne). 2021;12:710240.CrossRefPubMed
17.
go back to reference Si Y, Fan W, Shan W, et al. Association between triglyceride glucose index and coronary artery Disease with type 2 Diabetes Mellitus in middle-aged and elderly people. Medicine. 2021;100(9):e25025.CrossRefPubMedPubMedCentral Si Y, Fan W, Shan W, et al. Association between triglyceride glucose index and coronary artery Disease with type 2 Diabetes Mellitus in middle-aged and elderly people. Medicine. 2021;100(9):e25025.CrossRefPubMedPubMedCentral
18.
go back to reference Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation Myocardial Infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.CrossRefPubMedPubMedCentral Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation Myocardial Infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.CrossRefPubMedPubMedCentral
19.
go back to reference Wang L, Cong H-L, Zhang J-X, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with Diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.CrossRefPubMedPubMedCentral Wang L, Cong H-L, Zhang J-X, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with Diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.CrossRefPubMedPubMedCentral
20.
go back to reference Zhang Y, Ding X, Hua B, et al. Predictive effect of triglyceride–glucose index on clinical events in patients with type 2 Diabetes Mellitus and acute Myocardial Infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43.CrossRefPubMedPubMedCentral Zhang Y, Ding X, Hua B, et al. Predictive effect of triglyceride–glucose index on clinical events in patients with type 2 Diabetes Mellitus and acute Myocardial Infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43.CrossRefPubMedPubMedCentral
21.
go back to reference Mao Q, Zhou D, Li Y, et al. The triglyceride-glucose index predicts coronary artery Disease Severity and Cardiovascular outcomes in patients with Non-ST-Segment elevation Acute Coronary Syndrome. Dis Markers. 2019;2019:6891537.CrossRefPubMedPubMedCentral Mao Q, Zhou D, Li Y, et al. The triglyceride-glucose index predicts coronary artery Disease Severity and Cardiovascular outcomes in patients with Non-ST-Segment elevation Acute Coronary Syndrome. Dis Markers. 2019;2019:6891537.CrossRefPubMedPubMedCentral
22.
go back to reference Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery Disease. Cardiovasc Diabetol. 2022;21(1):168.CrossRefPubMedPubMedCentral Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery Disease. Cardiovasc Diabetol. 2022;21(1):168.CrossRefPubMedPubMedCentral
23.
go back to reference Gao A, Liu J, Hu C, et al. Association between the triglyceride glucose index and coronary collateralization in coronary artery Disease patients with chronic total occlusion lesions. Lipids Health Dis. 2021;20(1):140.CrossRefPubMedPubMedCentral Gao A, Liu J, Hu C, et al. Association between the triglyceride glucose index and coronary collateralization in coronary artery Disease patients with chronic total occlusion lesions. Lipids Health Dis. 2021;20(1):140.CrossRefPubMedPubMedCentral
24.
go back to reference Girasis C, Farooq V, Diletti R, et al. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery Disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac Surgery). JACC Cardiovasc Interv. 2013;6(12):1250–60.CrossRefPubMed Girasis C, Farooq V, Diletti R, et al. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery Disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac Surgery). JACC Cardiovasc Interv. 2013;6(12):1250–60.CrossRefPubMed
25.
go back to reference Askina L, Tanriverdib O. Is the Atherogenic Index of Plasma (AIP) a Cardiovascular Disease marker? Cor Vasa. 2023;65:100–3.CrossRef Askina L, Tanriverdib O. Is the Atherogenic Index of Plasma (AIP) a Cardiovascular Disease marker? Cor Vasa. 2023;65:100–3.CrossRef
26.
go back to reference Denimal D, Nguyen A, Pais de Barros J-P, et al. Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome. Atherosclerosis. 2016;246:106–14.CrossRefPubMed Denimal D, Nguyen A, Pais de Barros J-P, et al. Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome. Atherosclerosis. 2016;246:106–14.CrossRefPubMed
27.
go back to reference Zheng Y, Li C, Yang J, et al. Atherogenic index of plasma for non-diabetic, coronary artery Disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc Diabetol. 2022;21(1):29.CrossRefPubMedPubMedCentral Zheng Y, Li C, Yang J, et al. Atherogenic index of plasma for non-diabetic, coronary artery Disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc Diabetol. 2022;21(1):29.CrossRefPubMedPubMedCentral
28.
go back to reference Zhao Q, Zhang T-Y, Cheng Y-J, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 Diabetes Mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.CrossRefPubMedPubMedCentral Zhao Q, Zhang T-Y, Cheng Y-J, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 Diabetes Mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.CrossRefPubMedPubMedCentral
29.
go back to reference Tai S, Fu L, Zhang N, et al. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 Diabetes. Cardiovasc Diabetol. 2022;21(1):161.CrossRefPubMedPubMedCentral Tai S, Fu L, Zhang N, et al. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 Diabetes. Cardiovasc Diabetol. 2022;21(1):161.CrossRefPubMedPubMedCentral
30.
go back to reference Zhang Y, Ding X, Hua B, et al. High triglyceride-glucose index is Associated with Poor Cardiovascular outcomes in nondiabetic patients with ACS with LDL-C below 1.8 mmol/L. J Atheroscler Thromb. 2022;29(2):268–81.CrossRefPubMed Zhang Y, Ding X, Hua B, et al. High triglyceride-glucose index is Associated with Poor Cardiovascular outcomes in nondiabetic patients with ACS with LDL-C below 1.8 mmol/L. J Atheroscler Thromb. 2022;29(2):268–81.CrossRefPubMed
31.
go back to reference He J, Yang M, Song C et al. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery Disease and prediabetes or Diabetes. J Endocrinol Invest. 2023. He J, Yang M, Song C et al. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery Disease and prediabetes or Diabetes. J Endocrinol Invest. 2023.
32.
go back to reference He J, Bian X, Song C, et al. High neutrophil to lymphocyte ratio with type 2 Diabetes Mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol. 2022;21(1):156.CrossRefPubMedPubMedCentral He J, Bian X, Song C, et al. High neutrophil to lymphocyte ratio with type 2 Diabetes Mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol. 2022;21(1):156.CrossRefPubMedPubMedCentral
Metadata
Title
High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study
Authors
Jining He
Sheng Yuan
Chenxi Song
Yanjun Song
Xiaohui Bian
Guofeng Gao
Kefei Dou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02016-x

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine